Imaging Technology

APRIL 26, 2023

The guideline is published in Practical Radiation Oncology. The guideline task force also created algorithms on the optimal clinical scenarios for local therapy and the different types of local therapy available for these patients.

Radiation Oncology 97

Radiation Oncology Clinic Radiation Disease 97

Aidoc

JULY 19, 2023

Becker’s Hospital Review recently released their list highlighting the “Great Hospitals in America.” Each of the facilities “are renowned for clinical excellence, patient safety, innovation efforts, research and education, patient satisfaction and more.”

Hospital 52

Hospital Clinic Radiation Oncology Radiologist 52

Imaging Technology

JUNE 6, 2023

christine.book Tue, 06/06/2023 - 14:41 June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island (Mineola, NY) has placed an order for the treatment planning system RayStation.

Radiation Oncology 52

Radiation Oncology Hospital Radiation Clinic 52

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. Hope added. But prostate cancer will be different," Hope continued. "A

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

Imaging Technology

OCTOBER 5, 2023

At the meeting, held from October 1 to October 4, 2023, in San Diego, Simon Powell, MD, PhD, FRCP , Chair of MSK’s Department of Radiation Oncology and Enid A. Haupt Chair in Radiation Oncology, was honored with ASTRO’s Gold Medal Award. It is caused by an inherited mutation in the gene TP53.

Radiation Oncology 52

Radiation Oncology Insurance Radiation Clinic 52

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since the U.S. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent. please insert video here.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since the U.S. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52